231 related articles for article (PubMed ID: 21937683)
1. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression.
Kim SH; Park YY; Kim SW; Lee JS; Wang D; DuBois RN
Cancer Res; 2011 Nov; 71(22):7010-20. PubMed ID: 21937683
[TBL] [Abstract][Full Text] [Related]
2. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells.
Tanaka MN; Diaz BL; de Souza W; Morgado-Diaz JA
BMC Cell Biol; 2008 Dec; 9():63. PubMed ID: 19055708
[TBL] [Abstract][Full Text] [Related]
4. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
6. Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.
Rasmuson A; Kock A; Fuskevåg OM; Kruspig B; Simón-Santamaría J; Gogvadze V; Johnsen JI; Kogner P; Sveinbjörnsson B
PLoS One; 2012; 7(1):e29331. PubMed ID: 22276108
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.
Yang SF; Chen MK; Hsieh YS; Chung TT; Hsieh YH; Lin CW; Su JL; Tsai MH; Tang CH
J Biol Chem; 2010 Sep; 285(39):29808-16. PubMed ID: 20647315
[TBL] [Abstract][Full Text] [Related]
9. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.
Greenhough A; Wallam CA; Hicks DJ; Moorghen M; Williams AC; Paraskeva C
Oncogene; 2010 Jun; 29(23):3398-410. PubMed ID: 20348947
[TBL] [Abstract][Full Text] [Related]
10. Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells.
Zhao L; Wu Y; Xu Z; Wang H; Zhao Z; Li Y; Yang P; Wei X
J Cell Mol Med; 2012 Aug; 16(8):1840-55. PubMed ID: 22050691
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
Hata S; Nomura T; Iwasaki K; Sato R; Yamasaki M; Sato F; Mimata H
Oncol Rep; 2017 Jul; 38(1):120-128. PubMed ID: 28560449
[TBL] [Abstract][Full Text] [Related]
14. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.
Xia D; Holla VR; Wang D; Menter DG; DuBois RN
Cancer Res; 2010 Jan; 70(2):824-31. PubMed ID: 20068165
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis.
Nakayama T; Hirakawa H; Shibata K; Nazneen A; Abe K; Nagayasu T; Taguchi T
Oncol Rep; 2011 Apr; 25(4):929-35. PubMed ID: 21308352
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 augments IL-10 signaling and function.
Cheon H; Rho YH; Choi SJ; Lee YH; Song GG; Sohn J; Won NH; Ji JD
J Immunol; 2006 Jul; 177(2):1092-100. PubMed ID: 16818766
[TBL] [Abstract][Full Text] [Related]
18. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like 4 enhances metastasis and inhibits apoptosis via inducing bone morphogenetic protein 7 in colorectal cancer cells.
Li X; Chen T; Shi Q; Li J; Cai S; Zhou P; Zhong Y; Yao L
Biochem Biophys Res Commun; 2015 Nov; 467(1):128-34. PubMed ID: 26417691
[TBL] [Abstract][Full Text] [Related]
20. Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways.
Guan SM; Fu SM; He JJ; Zhang M
J Dent Res; 2011 Jan; 90(1):121-7. PubMed ID: 21057037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
